This document presents comments from a public forum regarding the FDA's social media guidelines, emphasizing the need for clear disclaimers and responsible use of regulated speech in healthcare communications. It discusses the importance of engaging healthcare stakeholders and the balance required between regulation and free speech, particularly in educational contexts. The document calls for ongoing discussions to shape adaptable guidelines, ensuring they don’t stifle conversation or inhibit the sharing of educational resources.
Related topics: